Surapong LertthammakiatPeerasit SitthiratUsanarat AnurathapanDuantida SongdejSamart PakakasamaAmpaiwan ChuansumritNattaphat PutawornsubSawitt SirasittikarnSataporn WantanawijarnPraguywan KadegasemSuradej HongengNongnuch SirachainanFaculty of Medicine, Ramathibodi Hospital, Mahidol UniversityMahidol Wittayanusorn School2020-11-182020-11-182020-09-04Thrombosis Journal. Vol.18, No.1 (2020)147795602-s2.0-85091923689https://repository.li.mahidol.ac.th/handle/20.500.14594/60083© 2020 The Author(s). Hemostatic changes and endothelial activations have been recognized in β-thalassemic patients after matched-donor hematopoietic stem cell transplantation (HSCT) but there are limited studies for haploidentical HSCT. This report demonstrates that the levels of hemostatic and endothelial markers, including thrombin antithrombin complex, prothrombin fragment, D-dimer, von Willebrand factor antigen and thrombomodulin levels, were not significantly different between haploidentical and matched-donor HSCT patients.Mahidol UniversityMedicineNo differences in hemostatic and endothelial activations between haploidentical and matched-donor hematopoietic stem cell transplantation in thalassemia diseaseArticleSCOPUS10.1186/s12959-020-00232-z